	A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma. Future Oncol Hatoum F, Dyer B, Heiligh J, Poehlman T, Zhang J, Jameel G, Mizelle S, Patel A, Schneider A, Fazili A, Johnson JS, Miller JW, Roman Souza G, Mahmoud N, Gullapalli K, Kim Y, Spiess PE, Gatenby R, Anderson ARA, Chahoud J. PMID: 42719952 [PubMed - as supplied by publisher]
	Pathology-Driven Diagnosis of Hereditary Leiomyomatosis and Renal Cell Carcinoma: A Clinicopathological and Genetic Analysis of Three Cases. IJU Case Rep Uchiyama T, Okazaki S, Ando S, Takeda M, Miyake M, Yoshizawa A. PMID: 42719935 [PubMed]
	Reply to Dr. Zhang's Letter to the Editor re: R.M. Bernardino, L.B. Yin, K. Lajkosz, et al. Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial. Eur Urol Open Sci 2025;82:52-8. Eur Urol Open Sci Bernardino RM, Yin LB, Lajkosz K, Winqust E, Cockburn JG, Jenjitranant P, Veloso R, O'Connell C, Benitez AM, Nguyen DD, Matthiesen R, Henrique R, Joshua AM, van der Kwast T, Fleshner NE. PMID: 42719708 [PubMed]
	Factors Associated With Self-Perceived Burden and Its Relationship With Quality of Life Among Patients With Bladder Cancer Undergoing Ileal Conduit Urinary Diversion: A Cross-Sectional Study. Cancer Med Xu JL, Fan CQ, Peng YQ, Yang XT, Tan Z, Gao SL, Tian YL, Liao DB, Ren HF, Liu CQ. PMID: 42717584 [PubMed - indexed for MEDLINE]
	Technical Feasibility of IVIM for Prostate Cancer Imaging Using High-Amplitude Whole-Body Gradient System With Spiral Readout and Velocity-Compensated Diffusion Encoding. NMR Biomed Molendowska M, Rashid IA, Foley K, Mueller L, Olsson LE, Brynolfsson P, Szczepankiewicz F. PMID: 42717576 [PubMed - indexed for MEDLINE]
	Cognitive Trajectories and Associated Factors in Prostate Cancer Survivors Over a 3-Year Prospective Study. Psychooncology Costa A, Severo M, Lopes C, Araújo N, Ferreira A, Lopes C, Pereira S, Lunet N. PMID: 42717557 [PubMed - indexed for MEDLINE]
	Primary Resistance to Immune Checkpoint Inhibitor Combination Therapy in Metastatic Renal Cell Carcinoma: Focus on Nivolumab Plus Ipilimumab. Int J Urol Numakura K, Abe N. PMID: 42717537 [PubMed - indexed for MEDLINE]
	Impact of Number of Lymph Nodes Sampled and Density of Positive Nodes on Outcomes Among Over 2000 Patients With Stage I to III Favorable Histology Wilms Tumor Enrolled on AREN03B2: A Children's Oncology Group Renal Tumor Study. Ann Surg Aldrink JH, Renfro LA, Kieran K, Tfirn IC, Ehrlich PF, Gow KW, Glick RD, Shamberger RC, Khanna G, Treece A, Dome JS, Fernandez CV, Geller JI, Mullen EA, Cost NG. PMID: 42717377 [PubMed - as supplied by publisher]
	Visceral Fat Volume and Inguinal Hernia After Robot-Assisted Radical Prostatectomy: A Three-Dimensional CT Analysis. Int J Urol Kano H, Izumi K, Nakagawa R, Kamijima T, Naito R, Makino T, Iwamoto H, Yaegashi H, Nohara T, Shigehara K, Mizokami A. PMID: 42717265 [PubMed - indexed for MEDLINE]
	Perioperative Safety and Long-Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real-World Study of 668 Patients. Int J Urol Yanagisawa T, Matsukawa A, Iwatani K, Hayashida Y, Okada Y, Kubota R, Kamikubo K, Taneda Y, Kondo H, Ito K, Miki J, Kimura T, Japanese En bloc TUR (JET) Study Group. PMID: 42717258 [PubMed - indexed for MEDLINE]
	Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: A GRADE-Assessed Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol Nadeem A, Javed D, Iqbal T, Klair AN, Nadeem F, Nadeem M, Sardar MB. PMID: 42717106 [PubMed - as supplied by publisher]
	Prognostic Value of Androgen Receptor (AR) Gene Alterations Detected in Circulating Tumor DNA (ctDNA) in Patients With Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis. Clin Genitourin Cancer Huang M, Yang J, Guo H, Huang C, Fu Y, Zhou L. PMID: 42716838 [PubMed - as supplied by publisher]
	Reply to T. Takahashi's Letter to the Editor re: Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. Eur Urol Nguyen DD, Najafabadi BT, Rosella LC, Dahm P, Guyatt GH, Kulkarni GS. PMID: 42716822 [PubMed - as supplied by publisher]
	Risk Stratification in Non-Muscle-Invasive Bladder Cancer in the Era of Expanding Therapeutic Options: Are Current Classifications Still Adequate? Fr J Urol Duquesne I, Chakra MA, de la Taille A, O'Donnell MA, Pignot G. PMID: 42716474 [PubMed - as supplied by publisher]
	Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era. Lancet Oncol Richters A, Bond MJG, Westgeest HM, Özdemir BC, Damen JAA, Aben KKH, Bex A. PMID: 42716079 [PubMed - as supplied by publisher]
	Prospective Evaluation of Circulating Tumor DNA in Metastatic Hormone-Sensitive Prostate Cancer. JCO Precis Oncol Nguyen CB, Tsung I, Lee JK, Pasquina LW, Kasputis A, Lovett JL, Graf RP, Redmond A, Cackowski FC, Heath EI, Smith DC, Alumkal JJ, Morgan TM, Reichert ZR. PMID: 42715508 [PubMed - indexed for MEDLINE]
	Uncovering the diagnostic potential of seminal fluid beyond fertility: cfDNA methylation analysis for the detection of clinically significant prostate cancer. PLoS One Geis J, Smith JF, Maddala T, Thoreson G, Michel K, Kaminetsky J, Belkoff L, Huang S, Griscom B, Hart JC, Bench S, Ardalani H, Rivas-Yepes L, Civello D, Clark-Langone KM. PMID: 42715227 [PubMed - indexed for MEDLINE]
	Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature. Acta Oncol Filis P, Lindskog M, Curman P, Kuzmina N, Krantz Å, Chatzidionysiou K, Costa Svedman F, Zerdes I. PMID: 42714143 [PubMed - indexed for MEDLINE]
	PD09-07 Durvalumab in Combination with Bacillus Calmette-GuÃ©rin for Bacillus Calmette-GuÃ©rin-NaÃ¯ve, High-Risk Non-Muscle-Invasive Bladder Cancer: Primary Results from a US-Based, Phase IIIB, Open-Label, Single-Arm, Multicenter Study (PATAPSCO): Erratum. J Urol Jayram G, Shore ND, Tyson M, Pieczonka C, Treasure P, Gadzinski A, Mazzarella B, Hodari M, Glover K, Hardikar S, Hahn NM. PMID: 42713894 [PubMed - in process]
	Predicting postoperative acute kidney injury after colorectal cancer surgery: development and internal validation of a clinical prediction model using a nationwide cohort. BJS Open Skovsgaard M, Munch PV, Heide-Jørgensen U, Iversen LH, Christiansen CF. PMID: 42713840 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 181341

Page 1 of 9068



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy